MJ Thomassen, JM Antal, MJ Connors, DP Meeker and HP Wiedemann
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, OH 44195.

Previous studies in our laboratory demonstrated that the synthetic surfactant Exosurf (Burroughs Wellcome Co.) inhibited endotoxin- stimulated cytokine secretion from human alveolar macrophages in vitro. The purpose of the present study was to further characterize the suppressive effects of Exosurf, which consists of dipalmitoylphosphatidylcholine (DPPC), cetyl alcohol (spreading agent), and tyloxapol (nonionic dispersing agent). Suppression was not stimulus specific in that Exosurf also significantly reduced cytokine production elicited by either Staphylococcus aureus or recombinant interleukin-1. Suppression was also mediated by a modified bovine surfactant (Survanta), which, in contrast to Exosurf, contains the surfactant- associated proteins B and C, and several different phospholipids, but no cetyl alcohol or tyloxapol. This suggests that suppression of macrophage cytokines is not specific to Exosurf. Both cell associated and secreted tumor necrosis factor and interleukin-1 were reduced by Exosurf, indicating that Exosurf is not simply blocking cytokine release. At 3 h, cytokine mRNA levels were not different between Exosurf-treated and untreated cells. However, at 8 and 24 h, cytokine mRNA levels were lower in Exosurf-treated cells. The observations that mRNA levels were decreased at 8 and 24 h and that cellular cytokine release was not blocked suggest that Exosurf's effect may in part be pretranslationally mediated. Collectively, these data add to previous work indicating that pulmonary surfactant may play a critical role in reducing inflammatory cytokine production associated with the adult respiratory distress syndrome and similar disorders.

This article has been cited by other articles:

				A. H. L. C. van Kaam, R. Lutter, R. A. Lachmann, J. J. Haitsma, E. Herting, M. Snoek, A. De Jaegere, J. H. Kok, and B. Lachmann Effect of ventilation strategy and surfactant on inflammation in experimental pneumonia Eur. Respir. J., July 1, 2005; 26(1): 112 - 117. [Abstract] [Full Text] [PDF]

				A. H. van Kaam, R. A. Lachmann, E. Herting, A. De Jaegere, F. van Iwaarden, L. A. Noorduyn, J. H. Kok, J. J. Haitsma, and B. Lachmann Reducing Atelectasis Attenuates Bacterial Growth and Translocation in Experimental Pneumonia Am. J. Respir. Crit. Care Med., May 1, 2004; 169(9): 1046 - 1053. [Abstract] [Full Text] [PDF]

				B. Raychaudhuri, S. Abraham, T. L. Bonfield, A. Malur, A. Deb, J. A. DiDonato, M. S. Kavuru, and M. J. Thomassen Surfactant Blocks Lipopolysaccharide Signaling by Inhibiting both Mitogen-Activated Protein and I{kappa}B Kinases in Human Alveolar Macrophages Am. J. Respir. Cell Mol. Biol., February 1, 2004; 30(2): 228 - 232. [Abstract] [Full Text] [PDF]

				R. G. Spragg, J. F. Lewis, W. Wurst, D. Hafner, R. P. Baughman, M. D. Wewers, and J. J. Marsh Treatment of Acute Respiratory Distress Syndrome with Recombinant Surfactant Protein C Surfactant Am. J. Respir. Crit. Care Med., June 1, 2003; 167(11): 1562 - 1566. [Abstract] [Full Text] [PDF]

				W. Huang, G. Wang, D. S. Phelps, H. Al-Mondhiry, and J. Floros Combined SP-A-bleomycin effect on cytokines by THP-1 cells: impact of surfactant lipids on this effect Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L94 - L102. [Abstract] [Full Text] [PDF]

				Y. Wu, M. Singer, F. Thouron, M. Alaoui-El-Azher, and L. Touqui Effect of surfactant on pulmonary expression of type IIA PLA2 in an animal model of acute lung injury Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L743 - L750. [Abstract] [Full Text] [PDF]

				M. Song and D. S. Phelps Comparison of SP-A and LPS effects on the THP-1 monocytic cell line Am J Physiol Lung Cell Mol Physiol, July 1, 2000; 279(1): L110 - L117. [Abstract] [Full Text] [PDF]

				H. B. Srinivasan, S. M. Vogel, D. Vidyasagar, and A. B. Malik Protective effect of lung inflation in reperfusion-induced lung microvascular injury Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H951 - H957. [Abstract] [Full Text] [PDF]

				R. Banerjee and R. R. Puniyani Exogenous Surfactant Therapy and Mucus Rheology in Chronic Obstructive Airway Diseases J Biomater Appl, January 1, 2000; 14(3): 243 - 272. [Abstract] [PDF]

				F. Pinot, H. Walti, H. P. Haagsman, B. S. Polla, and M. Bachelet Curosurf modulates cAMP accumulation in human monocytes through a membrane-controlled mechanism Am J Physiol Lung Cell Mol Physiol, January 1, 2000; 278(1): L99 - L104. [Abstract] [Full Text] [PDF]

				P. R. Miles, L. Bowman, K. M. K. Rao, J. E. Baatz, and L. Huffman Pulmonary surfactant inhibits LPS-induced nitric oxide production by alveolar macrophages Am J Physiol Lung Cell Mol Physiol, January 1, 1999; 276(1): L186 - L196. [Abstract] [Full Text] [PDF]

				C. LUTZ, D. CARNEY, C. FINCK, A. PICONE, L. A. GATTO, A. PASKANIK, E. LANGENBACK, and G. NIEMAN Aerosolized Surfactant Improves Pulmonary Function in Endotoxin-induced Lung Injury Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 840 - 845. [Abstract] [Full Text] [PDF]

				E. Israel-Assayag and Y. Cormier Surfactant modifies the lymphoproliferative activity of macrophages in hypersensitivity pneumonitis Am J Physiol Lung Cell Mol Physiol, December 1, 1997; 273(6): L1258 - L1264. [Abstract] [Full Text] [PDF]

				S. M. Manuel, Y. Guo, and S. Matalon Exosurf enhances adenovirus-mediated gene transfer to alveolar type II cells Am J Physiol Lung Cell Mol Physiol, October 1, 1997; 273(4): L741 - L748. [Abstract] [Full Text] [PDF]

				M. E. ERASMUS, G. J. H. HOFSTEDE, A. H. PETERSEN, H. P. HAAGSMAN, S. B. OETOMO, and J. PROP Effects of Early Surfactant Treatment Persisting for One Week after Lung Transplantation in Rats Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 567 - 572. [Abstract] [Full Text]

				R. J. Novick, K. E. Gehman, I. S. Ali, and J. Lee Lung Preservation: The Importance of Endothelial and Alveolar Type II Cell Integrity Ann. Thorac. Surg., July 1, 1996; 62(1): 302 - 314. [Abstract] [Full Text]

				A. Anzueto, R. P. Baughman, K. K. Guntupalli, J. G. Weg, H. P. Wiedemann, A. A. Raventos, F. Lemaire, W. Long, D. S. Zaccardelli, E. N. Pattishall, et al. Aerosolized Surfactant in Adults with Sepsis-Induced Acute Respiratory Distress Syndrome N. Engl. J. Med., May 30, 1996; 334(22): 1417 - 1422. [Abstract] [Full Text] [PDF]